Surgical Care Science, Department of Molecular Medicine and Surgery, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden.
Reproductive Health, Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
Br J Surg. 2018 Mar;105(4):410-418. doi: 10.1002/bjs.10686. Epub 2017 Nov 21.
Severe weight loss is experienced by patients with eating difficulties after surgery for oesophageal cancer. The aim of this prospective cohort study was to asssess the influence of eating difficulties and severe weight loss on health-related quality of life (HRQoL) up to 10 years after oesophagectomy.
Data on bodyweight and HRQoL were collected at 6 months, 3, 5 and 10 years in patients who underwent surgery for oesophageal cancer in Sweden between 2001 and 2005. Exposures were percentage weight loss, and eating difficulties defined by the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-OES18 questionnaire. Outcomes were HRQoL scores from the EORTC QLQ-C30 questionnaire. Repeated-measures ANOVA, adjusting for potential confounders, was used to assess the association between eating difficulties and weight loss (4 exposure groups) and HRQoL scores at each time point. Mean score differences (MDs) between time points or exposure groups were defined as clinically relevant in accordance with evidence-based interpretation guidelines.
In total, 92 of 104 10-year survivors (88·5 per cent) responded to the questionnaires. Weight loss was greatest within 6 months of surgery. Patients with eating difficulties with or without weight loss reported clinically and statistically significantly worsened HRQoL in almost all aspects. The largest MD was seen between 5 and 10 years after surgery for global quality of life, physical, role and social function (MD -22 to -30), as well for fatigue, nausea, dyspnoea, insomnia, appetite loss and diarrhoea (MD 24-36).
Eating difficulties are associated with deterioration in several aspects of HRQoL up to 10 years after surgery for oesophageal cancer.
食管癌手术后患者会出现严重的体重减轻。本前瞻性队列研究旨在评估术后 10 年内进食困难和严重体重减轻对健康相关生活质量(HRQoL)的影响。
在瑞典,2001 年至 2005 年间,对接受食管癌手术的患者在术后 6 个月、3、5 和 10 年时收集体重和 HRQoL 数据。暴露因素为体重减轻百分比和欧洲癌症研究与治疗组织(EORTC)QLQ-OES18 问卷定义的进食困难。结局为 EORTC QLQ-C30 问卷的 HRQoL 评分。采用重复测量方差分析,调整潜在混杂因素,评估进食困难和体重减轻(4 个暴露组)与每个时间点 HRQoL 评分之间的关系。根据循证解释指南,将时间点或暴露组之间的平均评分差异(MD)定义为有临床意义的差异。
共 104 名 10 年幸存者中的 92 名(88.5%)对问卷做出了回应。手术后 6 个月内体重减轻最明显。有或没有体重减轻的进食困难患者在几乎所有方面的 HRQoL 均明显恶化。手术后 5 至 10 年期间,全球生活质量、身体、角色和社会功能的 MD 最大(MD-22 至-30),疲劳、恶心、呼吸困难、失眠、食欲减退和腹泻的 MD 也最大(MD 24-36)。
食管癌手术后,进食困难与 HRQoL 的多个方面恶化有关,这种情况可持续至术后 10 年。